A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.
The Scientist
Most Recent
The Scientist recounts the year’s top science prize winners and top-notch scientists that passed away.
A list of this year's most high-profile retractions and controversies in science
A coauthor of the key paper that led to one of this year’s Nobel Prizes for Physiology or Medicine claims the recipient wasn’t involved in the research.
Congress orders the Environmental Protection Agency to review the toxicity ratings of some chemicals and improve its process for making such assessments.
More than one quarter of US researchers studying human embryonic stem cells say they’ve had trouble acquiring cell lines of interest.
A powerful consortium of research organizations in Europe speaks out against a recent ruling to ban patenting of research on human embryonic stem cells.
A controversial Boston University laboratory could open by the end of the month, but at a lower safety rating than originally planned.
A new Ebola vaccine candidate protects mice against death and can be produced quickly in response to a bioterrorism threat.
Lloyd Old, a researcher and former administrator of two cancer research institutes, passed away this week.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
